Management of medial femorotibial osteoarthritis: Epidemiology, and survival of unicompartmental knee arthroplasty versus valgus high tibial osteotomy in France. Study of 108,007 cases from the French National Hospitals Database.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 24 10 2022
revised: 16 06 2023
accepted: 26 06 2023
medline: 4 12 2023
pubmed: 1 10 2023
entrez: 30 9 2023
Statut: ppublish

Résumé

Unicompartmental knee arthroplasty (UKA) and valgus high tibial osteotomy (HTO) are two options for isolated medial femorotibial osteoarthritis in genu varum. In the absence of registries for osteotomies and for arthroplasty in the knee, epidemiological data are hard to obtain in France. We therefore performed a retrospective study, with the aims of: 1) estimating UKA and HTO survival without revision by total knee arthroplasty (TKA), and 2) assessing risk factors for revision according to treatment group. Medium-term survival is better with HTO than UKA in under-70-year-olds. All elderly patients undergoing HTO or UKA in the French National Hospitals Database for the period 2011-2020 were included: i.e., 108,007 patients; 43,537 HTO (29,330 male, 14,207 female; mean age 49.7 years, 95% CI 49.6-49.8) and 64,470 UKA (31,181 male, 33,289 female; mean age 60.5 years, 95% CI 60.5-60.6). Survival free of revision by TKA was 75.8% (95% CI=75.2-76.4) for UKA and 80.6% (95% CI=80.0-81.3) for HTO (p<0.00001). In UKA, revision risk factors comprised: low annual center volume (<17 UKAs per year) (HR=1.50; 95% CI=1.41-1.59), obesity (HR=1.25; 95% CI=1.18-1.32), and age <60years, with maximum risk for 50-59years (HR=2.41; 95% CI=1.83-3.16 in 50-59 year-olds). In HTO, revision risk factors comprised: obesity (HR=1.42; 95% CI=1.31-1.53), rheumatoid arthritis (HR=2.75; 95% CI=1.37-5.51), joint chondrocalcinosis (HR=2.01; 95% CI=1.18-3.39), and age >60years (HR=8.81; 95% CI=7.23-19.73 in 60-69-year-olds). Male gender was a protective factor against revision in both groups: UKA, HR=0.75 (95% CI=0.72-0.79); HTO, HR=0.73 (95% CI=0.69-0.77). The number of UKAs increased over the years, matching the increase in arthroplasty in France, with a decrease in HTOs until 2019. HTO showed better medium-term survival than UKA in under-70-year-olds in France. Even so, indications decreased in favor of UKA, although the respective risk factors differ. These findings suggest that conservative surgery still has a role, depending on osteoarthritis stage. III; retrospective comparative study.

Identifiants

pubmed: 37776952
pii: S1877-0568(23)00202-5
doi: 10.1016/j.otsr.2023.103692
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103692

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Auteurs

Allison Fitoussi (A)

Service de chirurgie orthopédique, hôpital Roger-Salengro, centre hospitalier universitaire (CHU) de Lille, place de Verdun, 59000 Lille, France. Electronic address: allison.fitoussi@gmail.com.

Julien Dartus (J)

Service de chirurgie orthopédique, hôpital Roger-Salengro, centre hospitalier universitaire (CHU) de Lille, place de Verdun, 59000 Lille, France.

Roger Erivan (R)

SIGMA Clermont, ICCF, université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, 63000 Clermont-Ferrand, France.

Gilles Pasquier (G)

Service de chirurgie orthopédique, hôpital Roger-Salengro, centre hospitalier universitaire (CHU) de Lille, place de Verdun, 59000 Lille, France.

Henri Migaud (H)

Service de chirurgie orthopédique, hôpital Roger-Salengro, centre hospitalier universitaire (CHU) de Lille, place de Verdun, 59000 Lille, France.

Sophie Putman (S)

Service de chirurgie orthopédique, hôpital Roger-Salengro, centre hospitalier universitaire (CHU) de Lille, place de Verdun, 59000 Lille, France; ULR 2694 METRICS, université de Lille, CHU de Lille, 59000 Lille, France.

Emmanuel Chazard (E)

ULR 2694 METRICS, université de Lille, CHU de Lille, 59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH